Global Pet Animal Health Product Market Top Leading Players with Strategies and Forecast 2028

The global pet animal health product market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). The rise in the incidence of zoonotic diseases is driving the pet animal health product market. Increased acceptance of pets into a friendly environment is causing increased contact with the disease that spreads animal diseases around the world. Increased awareness of preventive measures and increasing availability of treatment options are driving the demand for pet animal health products market during forecasting. According to the Center for Disease Control, each year thousands of Americans become ill as a result of the transmission of disease to animals.

The use of animals as a tool in drug discovery is important because research into many genetic diseases and prolonged diseases cannot be approved for human testing is further creating demand for such products. In the US only, each year, thousands of rats and monkeys are used as experimental subjects in research laboratories. Animal studies are used in the development of new surgical techniques, testing new drugs for safety, and research on healthy eating. Animals are very important in research that includes long-lasting deteriorating diseases because such diseases can be easily solved in animals by comparison, which promotes an increase in market size.

According to the OIE-World Organization of Animal Health 2017 survey, Public-Private Partnership in the animal health sector has the potential to improve the quality of animal services across the globe.  Due to the restructuring of dynamic and sustainable programs that contribute to the health and welfare of human inhabitants. For instance, in January 2021 – Boehringer Ingelheim, an animal health leader, has announced a partnership with PetMedix to develop veterinary antimicrobials using the Ky9 PetMedix patent platform. As part of the partnership, Boehringer Ingelheim is bringing these treatments to the market and PetMedix is beginning to find activities that are vital targets.

Additionally, in October 2020, Boehringer Ingelheim announced a strategic partnership with Henke-Sass, Wolf to develop an improved intramuscular needle-free vaccine for pigs around weaning until the end of nursery. This device will be available under two different brand names FreVAX and EPIG. Such product launches are anticipated to drive the market growth.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product
  • By Animal
  • By End-user
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Bayer AG, Boehringer Ingelheim International GmbH, CSL ltd., Merck & Co.Inc., Novartis AG,among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Pet Animal Health Product Market Report by Segment

By Product

• Drugs

Anti-Infectives

Anti-Inflammatory

Parasiticides

Others

• Vaccines
• Feed
• Diagnostics

Instruments

Reagents & Consumables

By Animal

• Livestock Animals
• Companion Animals

By End-user

• Veterinary Hospital & Clinics
• Animal Cae& Rehabilitation Centers
• Diagnostic Centers
• Others

Global Pet Animal Health Product Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa